Which hedge funds own LCTX? LINEAGE CELL THERAPEUTICS IN, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in LCTX (LINEAGE CELL THERAPEUTICS IN) in their Q2 2026 13F filings, worth $71.8m in total. The largest holder by portfolio weight is Broadwood Capital INC at 3.4% of its book. 14 exited: Armistice Capital, LLC, Brevan Howard Capital Management LP, Catalyst Funds Management Pty LTD.
8tracked managers holding
0opened this quarter
14exited this quarter
Which hedge funds hold LCTX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Broadwood Capital INC | Q2 2026 | 3.4% | $64.9m | 49,560,992 | 0% | held |
| Millennium Management LLC | Q2 2026 | 0.0% | $4.0m | 3,018,567 | -46% | reduced |
| Marshall Wace, LLP | Q2 2026 | 0.0% | $1.7m | 1,282,347 | -58% | reduced |
| Squarepoint Ops LLC | Q2 2026 | 0.0% | $582.7k | 444,774 | 211% | added |
| Voleon Capital Management LP | Q2 2026 | 0.0% | $60.9k | 46,478 | -46% | reduced |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $558.3k | 426,169 | 225% | added |
| Boothbay Fund Management, LLC | Q2 2026 | 0.0% | $13.1k | 10,000 | 0% | held |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $72.0k | 54,947 | -38% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Armistice Capital, LLC | 1.9% | $5.0m |
| Brevan Howard Capital Management LP | 0.0% | $295.1k |
| Catalyst Funds Management Pty LTD | 0.1% | $269.1k |
| Ctc Alternative Strategies, Ltd. | 0.1% | $24.2k |
| Diametric Capital, LP | 0.1% | $93.3k |
| ExodusPoint Capital Management, LP | 0.0% | $33.4k |
| Gsa Capital Partners LLP | 0.1% | $292.0k |
| Hudson Bay Capital Management LP | 0.0% | $175.8k |
| Jain Global LLC | 0.0% | $192.8k |
| Nine Masts Capital LTD | 0.0% | $46.1k |
| Prelude Capital Management, LLC | 0.0% | $23.6k |
| Qube Research & Technologies LTD | 0.0% | $410.1k |
| Schonfeld Strategic Advisors LLC | 0.0% | $75.9k |
| SummitTX Capital, L.P. | 0.0% | $96.1k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of LCTX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $73.6m |
| Q1 2026 | 24 | $103.6m |
| Q4 2025 | 2 | $4.3m |
| Q3 2025 | 1 | $3.2m |
| Q2 2025 | 1 | $1.8m |
| Q1 2025 | 1 | $1.0m |
| Q4 2024 | 1 | $1.1m |
| Q3 2024 | 1 | $178.4k |
| Q2 2024 | 1 | $582.0k |
| Q1 2024 | 2 | $785.1k |
| Q4 2023 | 2 | $164.1k |
| Q3 2023 | 2 | $70.1k |
| Q2 2023 | 2 | $79.1k |
| Q1 2023 | 2 | $20.8k |
| Q4 2022 | 1 | $109 |
| Q3 2022 | 1 | $0 |
Counts every tracked manager that disclosed LCTX in that quarter's filing, including managers that have since stopped filing.